Surveillance and Response to Imported Malaria During the COVID-19 Epidemic - Anhui Province, China, 2019-2021

China CDC Wkly. 2022 Jul 15;4(28):622-625. doi: 10.46234/ccdcw2022.135.

Abstract

What is already known about this topic?: China was certified malaria-free on June 30, 2021. However, imported malaria continuously threatens the effort to prevent re-establishment of malaria in China.

What is added by this report?: Measures such as international travel restrictions, entry quarantine, and screening in fever clinics during the coronavirus disease 2019 (COVID-19) period were associated with a significant decrease of imported malaria cases in Anhui Province, a higher proportion of non-Plasmodium falciparum (non-P. falciparum) malaria reported infections, and a higher proportion of cases requiring medical attention at their initial visit.

What are the implications for public health practices?: It is necessary to be vigilant about imported malaria during the COVID-19 epidemic, especially for non-P. falciparum infections which are more difficult to detect, and to promote research, development, and introduction of more sensitive and specific point-of-care detection methods for non-P. falciparum species.

Keywords: Malaria; Response; Surveillance.

Grants and funding

Supported by the National Science and Technology Major Program of China (No. 2018ZX10101002-002-005)